Form 4: Esquire Financial Holdings Executive Files Form 4 Detailing Stock Transactions
SEC Form 4 Filing
Eric S. Bader, EVP and COO of Esquire Financial Holdings, reported stock transactions including the vesting of restricted stock and stock options.
Summary
- Eric S. Bader, the Executive Vice President and Chief Operating Officer of Esquire Financial Holdings, filed a Form 4 on December 12, 2024.
- The filing details transactions involving common stock, including the vesting of restricted stock and stock options.
- The restricted stock vests in three equal annual installments, with vesting dates commencing on December 10, 2022, December 19, 2023, December 16, 2024, December 9, 2025, December 19, 2026, and December 15, 2027.
- The stock options, granted on September 1, 2017, at a price of $12.50 per share, are fully vested and expire on September 1, 2026.
- The filing indicates a total of 29,125 shares of common stock are involved in the restricted stock transactions.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, indicating standard executive compensation practices. It is neither particularly positive nor negative, but rather expected.
Positives
- The vesting of restricted stock aligns executive compensation with long-term company performance.
- The fully vested stock options provide an incentive for the executive to contribute to the company's success.
Industry Context
Form 4 filings are a standard part of regulatory compliance for publicly traded companies, providing transparency into insider transactions.
Comparison to Industry Standards
- The vesting schedule of restricted stock over multiple years is a common practice in executive compensation packages.
- Stock options with a 10-year term are also a typical incentive for executives in the financial industry.
- The specific vesting dates and terms are unique to Esquire Financial Holdings and its compensation policies.
Stakeholder Impact
- The vesting of restricted stock and stock options may have a minor positive impact on shareholder sentiment, as it aligns executive interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 2017-09-01 | Grant date of stock options at $12.50 per share. |
| 2022-12-10 | First vesting date for restricted stock. |
| 2023-12-19 | Second vesting date for restricted stock. |
| 2024-12-10 | Date of the Form 4 filing. |
| 2024-12-12 | Date of signature on the Form 4. |
| 2024-12-16 | Third vesting date for restricted stock. |
| 2025-12-09 | Fourth vesting date for restricted stock. |
| 2026-09-01 | Expiration date of stock options. |
| 2026-12-19 | Fifth vesting date for restricted stock. |
| 2027-12-15 | Sixth vesting date for restricted stock. |
Keywords
Form 4, stock options, restricted stock, executive compensation, insider trading, Esquire Financial Holdings, vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.